http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#Head http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#assertion http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#provenance http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#pubinfo http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#assertion http://purl.obolibrary.org/obo/DOID_2275 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_2275 http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01060 http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#association http://www.w3.org/2000/01/rdf-schema#label moxatag is a penicillin class antibacterial indicated for the treatment of tonsillitis and or pharyngitis secondary to streptococcus pyogenes 1 tonsillitis and or pharyngitis moxatag is a penicillin class antibacterial indicated for the treatment of tonsillitis and or pharyngitis secondary to streptococcus pyogenes s pyogenes to reduce the development of drug resistant bacteria and maintain the effectiveness of moxatag and other antibacterial drugs moxatag should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB01060 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#provenance http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#pubinfo http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#sig http://purl.org/nanopub/x/hasSignature Pgd1MDUcjAo/kQlsQmjSk4zZ9hhE8AZctFtGXoSYQWyeYlLI+pKFVdspmUk+tPGZqzhIJVyfue/8gvP80RHMflBzfPSPUY6wJcnFMmtvoTaPbifE4ky5CU2vpu9piKkU4J6vyqNnIUqlbepJbHAjpbNA/H0mDr8FBawa2JO00Ig= http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg http://purl.org/dc/terms/created 2021-06-18T08:34:17.533+02:00 http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA-GsogdhDIpKHoVgbT2qXE6IRIu-e5iZqug-XR591dZg https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs